BCAX — Bicara Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Bicara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Bicara Therapeutics Appoints Ryan Cohlhepp As President & CEO Effective January 2027
Brief: Bicara Therapeutics Announces Appointments Of Jeremy Bender And Christy Oliger To Board Of Directors
Brief: Bicara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Biocon's Mazumdar-Shaw sets out 5-year succession plan, names niece Claire as successor (updated)
Biocon chair Kiran Mazumdar-Shaw identifies successor as Indian pharma firm plans transition
Brief: Bicara Therapeutics Reports Fourth Quarter And Full Year 2025 Financial Results And Provides Business Update
Brief: Bicara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight
Bicara Therapeutics rises after $150 mln equity raise
Brief: Bicara Therapeutics Says Co. Prices Public Offering Of 7,175,000 Shares At $16.00 Each
Brief: Bicara Therapeutics Announces Proposed Public Offering of Common Stock
Brief: Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses In 1L R/M HPV-Negative HNSCC
Brief: Bicara Therapeutics Announces Phase 3 Optimal Dose And Provides 2026 Corporate Outlook
U.S. RESEARCH ROUNDUP- Autozone, Coursera, Lennar